Showing results (201-210 of 235) with videos related to
Sort By:
Pageof 24
Bioorganic & Medicinal Chemistry|July 27, 2010
Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitrilesAbdelouahid Samadi, José Marco-Contelles, Elena Soriano, et al.ACS Chemical Neuroscience|June 15, 2013
PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in miceSilvia Lorrio, Alejandro Romero, Laura González-Lafuente, et al.Diagnostics (Basel, Switzerland)|January 25, 2025
Deep Learning in Oral Hygiene: Automated Dental Plaque Detection via YOLO Frameworks and Quantification Using the O'Leary IndexAlfonso Ramírez-Pedraza, Sebastián Salazar-Colores, Crystel Cardenas-Valle, et al.Critical Reviews in Food Science and Nutrition|June 1, 2021
New applications of advanced instrumental techniques for the characterization of food allergenic proteinsSara Benedé, Daniel Lozano-Ojalvo, Susana Cristobal, et al.Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|March 27, 2021
The key to the allergenicity of lipid transfer protein (LTP) ligands: A structural characterizationZulema Gonzalez-Klein, Bruno Cuevas-Zuviria, Andrea Wangorsch, et al.Journal of Clinical Microbiology|January 29, 2016
Propionibacterium acnes: Disease-Causing Agent or Common Contaminant? Detection in Diverse Patient Samples by Next-Generation SequencingSarah Mollerup, Jens Friis-Nielsen, Lasse Vinner, et al.Antioxidants (Basel, Switzerland)|September 28, 2023
Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4Alejandra Palomino-Antolín, Céline Decouty-Pérez, Víctor Farré-Alins, et al.Journal of Medicinal Chemistry|October 14, 2016
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 ActivatorsMohamed Benchekroun, Alejandro Romero, Javier Egea, et al.Journal of Medicinal Chemistry|April 11, 2022
Synthesis and Pharmacological Evaluation of New <i>N</i>-Sulfonylureas as NLRP3 Inflammasome Inhibitors: Identification of a Hit Compound to Treat GoutPaloma Narros-Fernández, Mourad Chioua, Sonia A Petcu, et al.Neuropharmacology|December 12, 2012
Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemiaSilvia Lorrio, Vanessa Gómez-Rangel, Pilar Negredo, et al.Pageof 24